PwC to Exclude Weight-Loss Drugs from Employee Health Plans
In a significant move, PwC has decided to exclude weight-loss drugs from its employee health plans. This decision comes amidst growing concerns over the escalating costs of these medications, which are primarily dominated by pharmaceutical giants Eli Lilly and Novo …
Read more →